Assessment of Neurodevelopment in Infants With and Without Exposure to Asymptomatic or Mild Maternal SARS-CoV-2 Infection During Pregnancy
Firestein M, Shuffrey L, Hu Y, Kyle M, Hussain M, Bianco C, Hott V, Hyman S, Kyler M, Rodriguez C, Romero M, Lopez H, Alcántara C, Amso D, Austin J, Bain J, Barbosa J, Battarbee A, Bruno A, Ettinger S, Factor-Litvak P, Gilboa S, Goldman S, Gyamfi-Bannerman C, Maniatis P, Marsh R, Morrill T, Mourad M, Muhle R, Newes-Adeyi G, Noble K, O’Reilly K, Penn A, Reichle L, Sania A, Semenova V, Silver W, Smotrich G, Tita A, Tottenham N, Varner M, Welch M, Zork N, Garey D, Fifer W, Stockwell M, Monk C, Dawood F, Dumitriu D. Assessment of Neurodevelopment in Infants With and Without Exposure to Asymptomatic or Mild Maternal SARS-CoV-2 Infection During Pregnancy. JAMA Network Open 2023, 6: e237396. PMID: 37036706, PMCID: PMC10087058, DOI: 10.1001/jamanetworkopen.2023.7396.Peer-Reviewed Original ResearchMeSH KeywordsAdultChildChild, PreschoolCohort StudiesCOVID-19Cross-Sectional StudiesFemaleHumansInfantInfant, NewbornMalePregnancyPregnancy Complications, InfectiousPrenatal Exposure Delayed EffectsProspective StudiesSARS-CoV-2ConceptsMaternal SARS-CoV-2 infectionSARS-CoV-2 infectionInfant neurodevelopmentPrenatal exposureCohort studyNeurodevelopmental outcomesPregnant individualsMild SARS-CoV-2 infectionAsymptomatic SARS-CoV-2 infectionGross motorFine motorMultisite prospective cohort studySubdomain scoresSARS-CoV-2 exposureProspective cross-sectional studyAssessment of neurodevelopmentProspective cohort studyInfant neurodevelopmental outcomesMean maternal ageInfants of mothersTrimester of exposureInfant gestational ageCross-sectional studyMode of deliveryNon-Hispanic ethnicity